Diabetes

A team of Iranian researchers unveils the first meta-analysis on the dose-response association of aerobic exercise with weight, waist circumference and body fat in overweight and obese people.

Get the info you need on this new dosage form, part of our drug news roundup for April.

Patients using icodec tend to have a higher incidence of hypoglycemic events compared to glargine or degludec, especially on days 2–4 of the weekly dosing cycle.

Research suggests bioactive compounds in chocolate may help reduce the risk of type 2 diabetes. But not all chocolate offers the same benefits.

Experts from the International Geriatric Diabetes Society recently developed the ‘4S Pathway.’

Large cohort study finds patients taking GLP-1 RAs undergoing common surgical procedures have no increased risk of postoperative aspiration pneumonia.

Researchers at the University of Waterloo are close to commercializing these next-generation monitoring tool.

Students at the University of Ottawa launch biomanufacturing platform to produce diabetes drugs.

The postpartum period is a great time to check in with women who had gestational diabetes, according to this UofT medicine professor.

Researchers introduce the “4S Pathway” to help manage diabetes regimens in older individuals experiencing difficulties with their current glycemic management approach.